Document is current
Any future updates will be listed below
-
Authors
Chiloiro, Sabrina
Giampietro, Antonella
Infante, Amato
Mattogno, Pier Paolo
Lauretti, Liverana
Olivi, Alessandro
De Marinis, Laura
Pontecorvi, Alfredo
Doglietto, Francesco
Bianchi, Antonio
-
Funding
Funding for this research was provided by:
Università Cattolica del Sacro Cuore (D1-2023)
- License Information
-
More Information
Article History
Accepted: 26 April 2024
First Online: 7 May 2024
Declarations
:
: Declaration of competing interest SC, AB, AG, LDM has served as investigator for clinical trials funded by Novartis, Pfizer, Ipsen and Crinetics. SC and AB received grants from Pfizer. SC won the 2022 Arrigo Recordati Research Grant. All the authors declare that there are no conflict of interest that could be perceived as prejudicing the impartiality of this paper.
: Registry databases were approved by Institutional Review Board (ID:5367) and informed consent was waived for individual patients.
: (A waiver of subject consent was approved).
: (All authors approve the submission).
